IL106917A0 - Compositions for the treatment of skin disorders - Google Patents

Compositions for the treatment of skin disorders

Info

Publication number
IL106917A0
IL106917A0 IL106917A IL10691793A IL106917A0 IL 106917 A0 IL106917 A0 IL 106917A0 IL 106917 A IL106917 A IL 106917A IL 10691793 A IL10691793 A IL 10691793A IL 106917 A0 IL106917 A0 IL 106917A0
Authority
IL
Israel
Prior art keywords
compositions
treatment
skin disorders
disorders
skin
Prior art date
Application number
IL106917A
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Priority to IL106917A priority Critical patent/IL106917A0/en
Publication of IL106917A0 publication Critical patent/IL106917A0/en

Links

IL106917A 1993-09-06 1993-09-06 Compositions for the treatment of skin disorders IL106917A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL106917A IL106917A0 (en) 1993-09-06 1993-09-06 Compositions for the treatment of skin disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL106917A IL106917A0 (en) 1993-09-06 1993-09-06 Compositions for the treatment of skin disorders

Publications (1)

Publication Number Publication Date
IL106917A0 true IL106917A0 (en) 1993-12-28

Family

ID=11065246

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106917A IL106917A0 (en) 1993-09-06 1993-09-06 Compositions for the treatment of skin disorders

Country Status (1)

Country Link
IL (1) IL106917A0 (en)

Similar Documents

Publication Publication Date Title
IL121170A0 (en) Compositions for the treatment of dermatological disorders
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
ZA953256B (en) Skin treatment composition
HUP9802861A3 (en) Use of calendula glycosides for the treatment of psoriasis
IL127146A0 (en) Transdermal propentofylline compositions for the treatment of alzheimer's disease
GB9323808D0 (en) Composition containing zinc for the treatment of skin disorders
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
EP0524602A3 (en) Compositions for the treatment of inflammations of the skin
GB9405021D0 (en) Skin treatment composition
GB9510162D0 (en) Compositions for the treatment of skin conditions
IL113057A0 (en) Compositions for the treatment of dandruff
EP0981357A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
IL104132A0 (en) Compositions for the treatment of mammalian diseases
IL105285A0 (en) Compositions for the treatment of diabetes
GB2275191B (en) Use of antifungal compounds in the treatment of skin disorders
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
EP0979234A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
ZA952120B (en) Skin treatment composition
IL106917A0 (en) Compositions for the treatment of skin disorders
IL104756A0 (en) Composition for the treatment of glaucoma
IL119990A0 (en) Topical compositions for the treatment of skin diseases
ZA925983B (en) Pharmaceutical compositions for the treatment of skin disorders
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
AU5397994A (en) Treatment of skin disorders